scholarly journals Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders

2012 ◽  
Vol 42 (4) ◽  
pp. 366-372 ◽  
Author(s):  
Matthew E. Hirschtritt ◽  
Maria E. Pagano ◽  
Kelly M. Christian ◽  
Nora K. McNamara ◽  
Robert J. Stansbrey ◽  
...  
Keyword(s):  
Substance Use ◽  
Children And Adolescents ◽  
Treatment Response ◽  
Substance Use Disorders ◽  
Comorbid Depression ◽  
Fluoxetine Treatment

Substance use disorders in bipolar disorders: Clinical correlates and treatment response to mood stabilizers

2022 ◽  
Author(s):  
Giulia Menculini ◽  
Luca Steardo ◽  
Norma Verdolini ◽  
Federica Cirimbilli ◽  
Patrizia Moretti ◽  
...  
Keyword(s):  
Substance Use ◽  
Treatment Response ◽  
Substance Use Disorders ◽  
Bipolar Disorders ◽  
Mood Stabilizers ◽  
Clinical Correlates

Efficacy of antidepressants in substance use disorders with and without comorbid depression

2005 ◽  
Vol 78 (1) ◽  
pp. 1-22 ◽  
Author(s):  
Marta Torrens ◽  
Francina Fonseca ◽  
Gerard Mateu ◽  
Magí Farré
Keyword(s):  
Substance Use ◽  
Substance Use Disorders ◽  
Comorbid Depression

scholarly journals Childhood and adolescent risk factors for comorbid depression and substance use disorders in adulthood

2012 ◽  
Vol 37 (11) ◽  
pp. 1240-1247 ◽  
Author(s):  
Kerry M. Green ◽  
Katarzyna A. Zebrak ◽  
Kate E. Fothergill ◽  
Judith A. Robertson ◽  
Margaret E. Ensminger
Keyword(s):  
Risk Factors ◽  
Substance Use ◽  
Substance Use Disorders ◽  
Comorbid Depression ◽  
Adolescent Risk

Cognitive Therapy for Comorbid Depression

2014 ◽  
Author(s):  
Mark A. Whisman ◽  
Daniel BE
Keyword(s):  
Substance Use ◽  
Anxiety Disorders ◽  
Personality Disorders ◽  
Cognitive Therapy ◽  
Substance Use Disorders ◽  
Clinical Guidelines ◽  
Clinical Samples ◽  
Comorbid Depression ◽  
Axis Ii ◽  
Axis I

Depression often co-occurs with other Axis I and Axis II psychiatric disorders. This chapter presents a model for how cognitive therapy (CT) of depression can be adapted in conceptualizing and treating the complex set of issues and problems that often accompany comorbid depression. It begins with a discussion of the prevalence of comorbidity in community and clinical samples, then review the research on comorbidity and outcome to CT for depression, followed by a model for adapting or modifying CT for patients who present with depression and a comorbid Axis I or Axis II disorder. The chapter concludes with specific clinical guidelines for treating depression that co-occurs with anxiety disorders, substance use disorders, and personality disorders.

Integrated Treatment of Comorbid Depression and Substance Use Disorders

2001 ◽  
Vol 62 (9) ◽  
pp. 672-677 ◽  
Author(s):  
Dara A. Charney ◽  
Antonios M. Paraherakis ◽  
Kathryn J. Gill
Keyword(s):  
Substance Use ◽  
Substance Use Disorders ◽  
Integrated Treatment ◽  
Comorbid Depression
Sign in / Sign up

Export Citation Format

Share Document